Robert G. Gentles

Person

Wallingford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridinone compounds useful as T cell activators
- Patent number 11,866,430
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,221,129
- Issue date Mar 5, 2019
- ViiV Healthcare UK (No. 5) Limited
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,035,760
- Issue date Jul 31, 2018
- ViiV Healthcare UK (No. 5) Limited
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 9,855,230
- Issue date Jan 2, 2018
- ViiV Healthcare UK (No. 5) Limited
- Makonen Belema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycine chroman-6-sulfonamides for use as inhibitors of diacylglyce...
- Patent number 8,404,741
- Issue date Mar 26, 2013
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycine chroman-6-sulfonamides for use as inhibitors of diacylglyce...
- Patent number 8,354,548
- Issue date Jan 15, 2013
- Bristol-Myers Squibb Company
- Shuanghua Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,143,243
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,133,884
- Issue date Mar 13, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,652,004
- Issue date Jan 26, 2010
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 7,547,690
- Issue date Jun 16, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,541,351
- Issue date Jun 2, 2009
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,541,353
- Issue date Jun 2, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 7,538,102
- Issue date May 26, 2009
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,442
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,443
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,441
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,521,444
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,485,633
- Issue date Feb 3, 2009
- Bristol-Myers Squibb Company
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolobenzazepine HCV NS5B inhibitors
- Patent number 7,473,688
- Issue date Jan 6, 2009
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,456,166
- Issue date Nov 25, 2008
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,452,876
- Issue date Nov 18, 2008
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,399,758
- Issue date Jul 15, 2008
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,348,425
- Issue date Mar 25, 2008
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,153,848
- Issue date Dec 26, 2006
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...
- Publication number 20230061608
- Publication date Mar 2, 2023
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210277004
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20180086697
- Publication date Mar 29, 2018
- John A. BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20170304239
- Publication date Oct 26, 2017
- VIIV HEALTHCARE UK (NO.5) LIMITED
- Makonen BELEMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20160257645
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20140186299
- Publication date Jul 3, 2014
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20140045816
- Publication date Feb 13, 2014
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20130171098
- Publication date Jul 4, 2013
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20110311480
- Publication date Dec 22, 2011
- Bristol -Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglyce...
- Publication number 20110207772
- Publication date Aug 25, 2011
- Bristol -Myers Squibb Company
- Shuanghua Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglyce...
- Publication number 20110207749
- Publication date Aug 25, 2011
- Bristol -Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090280083
- Publication date Nov 12, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090275561
- Publication date Nov 5, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20090162318
- Publication date Jun 25, 2009
- Bristol -Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090074715
- Publication date Mar 19, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080227769
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226590
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226591
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226592
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080171015
- Publication date Jul 17, 2008
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS
- Publication number 20080146537
- Publication date Jun 19, 2008
- Bristol -Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070287694
- Publication date Dec 13, 2007
- Bristol -Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070275930
- Publication date Nov 29, 2007
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070270406
- Publication date Nov 22, 2007
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070270405
- Publication date Nov 22, 2007
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070184024
- Publication date Aug 9, 2007
- Bristol -Myers Squibb Company
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY

Robert G. Gentles

Person

Patents Grantslast 30 patents

Substituted bicyclic compounds useful as T cell activators

Naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Glycine chroman-6-sulfonamides for use as inhibitors of diacylglyce...

Glycine chroman-6-sulfonamides for use as inhibitors of diacylglyce...

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of Hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of Hepatitis C

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Compounds for the treatment of hepatitis C

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Inhibitors of HCV replication

Inhibitors of HCV replication

Patents Applicationslast 30 patents

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglyce...

Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglyce...

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors